JP5214884B2 - α放射性ヒドロキシアパタイト粒子 - Google Patents

α放射性ヒドロキシアパタイト粒子 Download PDF

Info

Publication number
JP5214884B2
JP5214884B2 JP2006553676A JP2006553676A JP5214884B2 JP 5214884 B2 JP5214884 B2 JP 5214884B2 JP 2006553676 A JP2006553676 A JP 2006553676A JP 2006553676 A JP2006553676 A JP 2006553676A JP 5214884 B2 JP5214884 B2 JP 5214884B2
Authority
JP
Japan
Prior art keywords
hydroxyapatite
radionuclide
treatment
alpha
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006553676A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007528373A5 (de
JP2007528373A (ja
Inventor
グロ ソルベルグ
ロイ ラーセン
Original Assignee
アルゲッタ エイエスエイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルゲッタ エイエスエイ filed Critical アルゲッタ エイエスエイ
Priority claimed from PCT/GB2005/000616 external-priority patent/WO2005079867A2/en
Publication of JP2007528373A publication Critical patent/JP2007528373A/ja
Publication of JP2007528373A5 publication Critical patent/JP2007528373A5/ja
Application granted granted Critical
Publication of JP5214884B2 publication Critical patent/JP5214884B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
JP2006553676A 2004-02-20 2005-02-18 α放射性ヒドロキシアパタイト粒子 Expired - Fee Related JP5214884B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0403856.8 2004-02-20
GBGB0403856.8A GB0403856D0 (en) 2004-02-20 2004-02-20 Composition
PCT/GB2005/000616 WO2005079867A2 (en) 2004-02-20 2005-02-18 Alpha-emitting hydroxyapatite particles

Publications (3)

Publication Number Publication Date
JP2007528373A JP2007528373A (ja) 2007-10-11
JP2007528373A5 JP2007528373A5 (de) 2008-04-03
JP5214884B2 true JP5214884B2 (ja) 2013-06-19

Family

ID=32040119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006553676A Expired - Fee Related JP5214884B2 (ja) 2004-02-20 2005-02-18 α放射性ヒドロキシアパタイト粒子

Country Status (13)

Country Link
JP (1) JP5214884B2 (de)
KR (2) KR101165518B1 (de)
CN (1) CN1972720B (de)
AT (1) ATE544492T1 (de)
DK (1) DK1735013T3 (de)
ES (1) ES2382041T3 (de)
GB (1) GB0403856D0 (de)
IL (1) IL177354A (de)
NO (1) NO20064232L (de)
NZ (1) NZ549080A (de)
PT (1) PT1735013E (de)
TW (1) TWI347194B (de)
ZA (1) ZA200606728B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3111959T (pt) * 2015-07-03 2017-12-14 Oncoinvent As Partículas e suspensões radioterapêuticas
US20170065731A1 (en) * 2015-09-06 2017-03-09 Medical Theranostics Inc. Method, Apparatus, and System for Radiation Therapy
CN106344927A (zh) * 2016-09-27 2017-01-25 大连理工大学 叶酸修饰的载药羟基磷灰石及其制备方法
CN121731510A (zh) * 2020-09-15 2026-03-27 昂科因凡特解决方案公司 尺寸可控的放射性标记粒子
JP2026503022A (ja) * 2023-01-05 2026-01-27 オンコインベント アクスィエ セルスカプ 腹膜がん治療に使用するためのα線放射性核種

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2119778T3 (es) * 1990-12-21 1998-10-16 Mallinckrodt Medical Inc Particulas en marcaje por radionucleidos utilizadas en sinovectomia por radiacion.
EP0734264B1 (de) * 1993-10-26 2004-02-18 Thomas Jefferson University Verbindungen die kolorektale krebszellen spezifisch binden und verfahren für ihre herstellung
WO1997001304A1 (en) * 1995-06-29 1997-01-16 Mallinckrodt Medical, Inc. Radiolabeled apatite particles containing a paramagnetic ion
BR0014877A (pt) * 1999-10-18 2002-06-11 Ferx Inc Veìculo magnético objetivado composto de ferro e materiais porosos para a distribuição objetivada de agentes biologicamente ativos
JP3836444B2 (ja) * 2002-05-30 2006-10-25 独立行政法人科学技術振興機構 ハイドロキシアパタイト複合体およびその製造方法、ならびに、それを用いた医療用材料

Also Published As

Publication number Publication date
GB0403856D0 (en) 2004-03-24
DK1735013T3 (da) 2012-05-21
KR20070038030A (ko) 2007-04-09
CN1972720A (zh) 2007-05-30
IL177354A0 (en) 2006-12-10
NZ549080A (en) 2011-01-28
KR20100060029A (ko) 2010-06-04
TWI347194B (en) 2011-08-21
ATE544492T1 (de) 2012-02-15
ZA200606728B (en) 2007-12-27
IL177354A (en) 2013-04-30
JP2007528373A (ja) 2007-10-11
KR101165518B1 (ko) 2012-07-16
NO20064232L (no) 2006-09-19
ES2382041T3 (es) 2012-06-04
TW200536558A (en) 2005-11-16
CN1972720B (zh) 2010-07-07
PT1735013E (pt) 2012-05-08

Similar Documents

Publication Publication Date Title
AU2005215234B2 (en) Alpha-emitting Hydroxyapatite particles
JP5219325B2 (ja) 骨標的錯体
CN112843260B (zh) 一种医用放射性二氧化硅微球及其制备方法与应用
EP3111959B1 (de) Radiotherapeutische partikel und suspensionen
US10918746B2 (en) Radioactive compositions and methods for their therapeutic use
JP5214884B2 (ja) α放射性ヒドロキシアパタイト粒子
MXPA06009375A (en) Alpha-emitting hydroxyapatite particles
JP2007528373A5 (de)
CN114667162A (zh) 放射性微粒和非放射性微粒的组合物
HK40076343A (en) Composition of radioactive and non-radioactive microparticles
HK1232446B (en) Radiotherapeutic particles and suspensions
HK1232446A1 (en) Radiotherapeutic particles and suspensions
HK1232446A (en) Radiotherapeutic particles and suspensions

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080215

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110118

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110407

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110414

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110719

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111011

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111219

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111227

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20120323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120411

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120814

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121109

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130212

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130228

R150 Certificate of patent or registration of utility model

Ref document number: 5214884

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160308

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees